Trials / Completed
CompletedNCT04002531
A One Visit Follow Up of Adults With Fabry Disease Who Started Long-term Enzyme Replacement Therapy As Children
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- Baylor Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to obtain follow up data on a cohort of well-studied patients with Fabry disease who have been on ERT since childhood for a total of about 15 years.
Detailed description
The long-term effect of initiating ERT in childhood is unknown. Prospective studies of Children with Fabry disease on 0.2 mg/kg agalsidase alfa every other week were performed. The patients were 7-17 years of age at initial study enrollment. The first open-label protocol was TKT023, a 6 months study (August 12, 2002-October 20, 2004) that was followed by an extension study TKT029 (June 10, 2004-June 15, 2011; ClinicalTrials.gov identifier NCT00084084). Since completing TKT029, all US patients were switched to commercial agalsidase beta. Therefore, these patients have now been treated for about 15 years.This study involves a one-visit follow up on these patients using the same protocol-driven studies as were used in TKT029. The long-term follow up data gathered will consist of a rare description of the disease profile in patients who were treated with ERT since childhood.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | General and Neurological examination | Information about your general health, neurological symptoms and current medications with be collected |
| OTHER | Vital signs | Height, weight, blood pressure, heart rate, and respiratory rate and temperature will be measured. |
| PROCEDURE | 12 lead electrocardiogram | A non-invasive test that measures the electrical activity of the heart |
| PROCEDURE | Echocardiogram | A non-invasive sonogram of the heart |
| PROCEDURE | Blood draw | Blood will be drawn to evaluate general health and renal function (kidney health) |
| PROCEDURE | Urine collection | Urine will be collection to evaluate renal function (kidney health) |
| PROCEDURE | 2-hour Holter Monitor | A non-invasive test that measures the electrical activity of the heart continuously over 2 hours |
| OTHER | Brief Pain Inventory questionnaire | A questionnaire about daily pain |
| OTHER | Quality of Life questionnaire | A questionnaire about the impact of disease on their activities of daily living and quality of life |
Timeline
- Start date
- 2018-11-10
- Primary completion
- 2019-12-13
- Completion
- 2019-12-13
- First posted
- 2019-06-28
- Last updated
- 2026-03-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04002531. Inclusion in this directory is not an endorsement.